Sperimentazione in fase di reclutamento = ; Sperimentazione in corso = ; Finanziato da un ente associato a IRDiRC = ; Membro di una ERN =

Sperimentazioni cliniche nazionali

STATI UNITI

Texas
IRVING

MOXIe: A Phase 2 Study of the Safety, Efficacy, and Pharmacodynamics of RTA 408 in the Treatment of Friedreich's Ataxia - AT

Reata Pharmaceuticals

Ulteriori dettagli

STATI UNITI

Texas
IRVING

CATALYST: A study of the efficacy and safety of bardoxolone methyl in patients with connective tissue disease-associated pulmonary arterial hypertension (Phase III) - ES (Completed)

Reata Pharmaceuticals

Ulteriori dettagli

STATI UNITI

Texas
IRVING

CARDINAL: A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients with Alport Syndrome - ES (terminated)

Reata Pharmaceuticals

Ulteriori dettagli